Submission Guidelines and Manuscript Preparation

The Journal of Hematology and Clinical Research (JHCR) welcomes high-quality manuscripts that contribute to the advancement of hematology, clinical medicine, and translational research. Authors are encouraged to follow these Submission Guidelines and Manuscript Preparation Instructions carefully to ensure smooth processing, rapid peer review, and professional publication.

Submission Methods

Preferred format: Microsoft Word (.docx). Include all figures, tables, and supplementary files as separate attachments.

Cover Letter Requirements

Each submission must include a brief cover letter addressed to the Editor-in-Chief, stating:

  • The significance and novelty of the research.
  • Confirmation that the work has not been published or under review elsewhere.
  • Details of any related conference presentations or preprints.
  • Declarations of conflicts of interest and funding sources.

Manuscript Files and Components

File Type Description Required/Optional
Main Manuscript Complete text file with title page, abstract, main text, references, tables, and figure captions. Required
Figures and Tables Each submitted separately in high resolution (≥300 dpi). Accepted formats: .jpg, .tif, .png. Required
Supplementary Material Additional datasets, videos, or appendices referenced in the main text. Optional
Cover Letter Statement of originality, novelty, and conflict of interest declaration. Required

Formatting Requirements

  • Text Format: Times New Roman, size 12, double-spaced.
  • Page Layout: A4 paper size, 1-inch margins on all sides.
  • Headings: Use boldface for section titles; avoid underlining.
  • Word Limits: Original Research (up to 5000 words), Case Reports (up to 2500 words), Reviews (up to 8000 words).

References and Citations

Follow the Vancouver (NLM) citation format. Reference numbers should be cited in the text using superscript numerals (e.g., “as previously reported3”). Examples:

  • Journal article: Doe J, Smith K. Advances in hematology research. J Hematol Clin Res. 2023;9(2):45–52.
  • Book: Brown A. Essentials of Clinical Hematology. Springer; 2021.
  • Online resource: World Health Organization. Guidelines for Blood Disorders. 2020. Available from: https://www.who.int

Ethical and Legal Considerations

  • Authors must comply with the Declaration of Helsinki for studies involving humans.
  • Animal research must follow institutional and national guidelines for ethical treatment.
  • All clinical trials should be registered in recognized trial registries (e.g., ClinicalTrials.gov).
  • Patient consent is mandatory for identifiable information or images.

Acknowledgments and Funding

Include funding agency names, grant numbers, and acknowledgments for individuals who contributed but do not meet authorship criteria.

Conflict of Interest Disclosure

Authors must disclose any personal, professional, or financial relationships that may influence their research. The statement should appear under the section titled “Conflict of Interest.”

Pre-Submission Checklist

  • [ ] Manuscript follows JHCR format (IMRaD structure, double-spaced).
  • [ ] All authors’ names, affiliations, and ORCID IDs are correct.
  • [ ] Figures and tables are uploaded separately in correct formats.
  • [ ] References follow NLM style and are cited sequentially.
  • [ ] Ethics approval and consent statements included where applicable.
  • [ ] Plagiarism check performed prior to submission (recommended via iThenticate).
  • [ ] Cover letter and conflict of interest statement attached.

Editorial and Review Workflow

Upon submission, manuscripts undergo an initial editorial screening to ensure compliance with scope and formatting. Eligible manuscripts are assigned to at least two independent reviewers for double-blind peer review.

The typical turnaround time from submission to initial decision is 3–4 weeks. Accepted manuscripts proceed to language editing, proof correction, and online publication under the CC BY 4.0 license.

Post-Acceptance and Proofing

After acceptance, authors receive proofs for approval. Minor corrections may be made at this stage. Once approved, the article is published online and assigned a DOI.

Note: Substantial changes (e.g., new data or authorship changes) after acceptance require Editor-in-Chief approval.

Data Availability Statement

All research manuscripts must include a Data Availability Statement describing where supporting data can be accessed, such as in institutional repositories, public databases, or upon reasonable request.

Frequently Asked Questions (FAQ)

Can I submit the same manuscript to another journal?

No. Simultaneous submissions are prohibited and may lead to rejection and reporting to COPE.

How long does the peer review take?

Typically 3–4 weeks, depending on reviewer availability and response time.

Can I upload a revised manuscript?

Yes. Authors can upload revised files directly through the submission portal with detailed responses to reviewer comments.

Is there a fee for submission?

No, JHCR charges no submission or review fees; only Article Processing Charges (APCs) apply after acceptance.

Contact Information

Editorial Office – Journal of Hematology and Clinical Research (JHCR)
Heighten Science Publications Inc.
Website: https://www.hematologyresjournal.com/
Email: [email protected]

Sources from the legacy site: Submission Guidelines (IMRaD structure, formatting, and pre-submission checklist). File preparation and format instructions. Figure/table requirements. Ethics and authorship compliance (ICMJE, COPE). Acknowledgment and conflict disclosures. Peer review and editorial process (double-blind). Data availability and preprint policy.

Copyright © 2016–2025 Journal of Hematology and Clinical Research (JHCR) – Heighten Science Publications Inc. Licensed under CC BY 4.0.